CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial

Phase 3Neutral
AI Analysis

Summary

Jim Cramer recommends holding Moderna shares following the company's Phase 3 cancer trial. Limited details are provided about the trial results or specifics in this headline-only article.

Clinical Trial Data

Phase

Phase 3

Importance:3/10
Sentiment:
0.00
ModernaMRNAPhase 3cancerclinical trialanalyst recommendation
Related Companies

Read the original article

Published by yahoo_finance on August 28, 2026 8:24 PM

Read Original